BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16520485)

  • 1. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Chavez-Tapia NC; Mendez-Sanchez N; Uribe M
    Ann Intern Med; 2006 Mar; 144(5):379; author reply 380. PubMed ID: 16520485
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Kida Y; Sato T
    Ann Intern Med; 2006 Mar; 144(5):379-80; author reply 380. PubMed ID: 16520484
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
    Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease.
    Powell EE; Jonsson JR; Clouston AD
    Ann Intern Med; 2005 Nov; 143(10):753-4. PubMed ID: 16287799
    [No Abstract]   [Full Text] [Related]  

  • 5. Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
    Tarantino G
    World J Gastroenterol; 2007 Sep; 13(35):4669-72. PubMed ID: 17729388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years.
    Kuchay MS; Misra A
    Diabetes Metab Syndr; 2020; 14(4):695-696. PubMed ID: 32442920
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summaries for patients. The metabolic syndrome and fatty liver disease.
    Ann Intern Med; 2005 Nov; 143(10):I70. PubMed ID: 16287788
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fatty liver and steatohepatitis].
    Saito T; Misawa K; Kawata S
    Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1855-9. PubMed ID: 16223146
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction: organ involvement in the cardiometabolic syndrome.
    Hayden MR; Stump CS; Sowers JR
    J Cardiometab Syndr; 2006; 1(1):16-24. PubMed ID: 17675904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome.
    Castro-Martínez MG; Banderas-Lares DZ; Ramírez-Martínez JC; Escobedo-de la Peña J
    Cir Cir; 2012; 80(2):128-33. PubMed ID: 22644007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments on "High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome".
    Jelic S; Perovic-Blagojevic I
    Endocr J; 2013; 60(6):835-6. PubMed ID: 23503327
    [No Abstract]   [Full Text] [Related]  

  • 13. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome].
    Carvalheira JB; Saad MJ
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):360-7. PubMed ID: 16767302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The liver in metabolic syndrome.
    Smith AD
    J R Soc Med; 2005 Jul; 98(7):336. PubMed ID: 15994602
    [No Abstract]   [Full Text] [Related]  

  • 16. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.
    Mahli A; Hellerbrand C
    Dig Dis; 2016; 34 Suppl 1():32-9. PubMed ID: 27548267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperlipidemia and hepatic dysfunction].
    Shiota G
    Nihon Naika Gakkai Zasshi; 2006 Jan; 95(1):8-14. PubMed ID: 16499201
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatty liver disease: the hepatic manifestation of metabolic syndrome.
    Gastaldelli A
    Hypertens Res; 2010 Jun; 33(6):546-7. PubMed ID: 20463681
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.